FDA Warning Letter For Pfizer Zyvox Promotion Charges Implied Superiority
This article was originally published in The Pink Sheet Daily
Executive Summary
A professional journal advertisement describes a higher cure rate for linezolid than for vancomycin in methicillin-resistant Staphylococcus aureus, a claim not supported by evidence, the agency says.
You may also be interested in...
DDMAC Letter Cites Pfizer Geodon Ad For Implying Superiority To Haloperidol
FDA also points to the journal ad’s lack of discussion of specific warnings for metabolic side effects and movement disorders.
DDMAC Letter Cites Pfizer Geodon Ad For Implying Superiority To Haloperidol
FDA also points to the journal ad’s lack of discussion of specific warnings for metabolic side effects and movement disorders.
Pfizer Pulls U.K. Ads Comparing Zyvox To Vancomycin
U.K.' s MHRA asked Pfizer to withdraw advertising for the antibiotic.